Filing Details
- Accession Number:
- 0001181431-13-015986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-11 16:24:09
- Reporting Period:
- 2013-03-07
- Filing Date:
- 2013-03-11
- Accepted Time:
- 2013-03-11 16:24:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021038 | A Henri Termeer | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-07 | 55,499 | $6.73 | 100,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $6.70 to $6.735. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.